These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29224849)

  • 1. Aptamers as potential therapeutic agents for ovarian cancer.
    Henri JL; Macdonald J; Strom M; Duan W; Shigdar S
    Biochimie; 2018 Feb; 145():34-44. PubMed ID: 29224849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic effects of aptamer-doxorubicin conjugates in an ovarian cancer cell line.
    Henri JL; Nakhjavani M; McCoombe S; Shigdar S
    Biochimie; 2023 Jan; 204():108-117. PubMed ID: 36155804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth.
    Zheng J; Zhao S; Yu X; Huang S; Liu HY
    Theranostics; 2017; 7(5):1373-1388. PubMed ID: 28435472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer.
    Alibolandi M; Ramezani M; Abnous K; Sadeghi F; Atyabi F; Asouri M; Ahmadi AA; Hadizadeh F
    J Control Release; 2015 Jul; 209():88-100. PubMed ID: 25912964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
    Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
    Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging cancer targets for aptamer delivery.
    de Franciscis V
    Biochimie; 2018 Feb; 145():45-52. PubMed ID: 28962871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of aptamers for cancer research.
    Zhou Z; Liu M; Jiang J
    Anal Biochem; 2018 May; 549():91-95. PubMed ID: 29548926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and targeting of EpCAM protein by ssDNA aptamer.
    Alshaer W; Ababneh N; Hatmal M; Izmirli H; Choukeife M; Shraim A; Sharar N; Abu-Shiekah A; Odeh F; Al Bawab A; Awidi A; Ismail S
    PLoS One; 2017; 12(12):e0189558. PubMed ID: 29245156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine.
    Xiang D; Shigdar S; Qiao G; Wang T; Kouzani AZ; Zhou SF; Kong L; Li Y; Pu C; Duan W
    Theranostics; 2015; 5(1):23-42. PubMed ID: 25553096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.
    Hays EM; Duan W; Shigdar S
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29189740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
    Zhu H; Li J; Zhang XB; Ye M; Tan W
    ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers.
    Yu Y; Liang C; Lv Q; Li D; Xu X; Liu B; Lu A; Zhang G
    Int J Mol Sci; 2016 Mar; 17(3):358. PubMed ID: 26978355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer.
    Rehmani H; Li Y; Li T; Padia R; Calbay O; Jin L; Chen H; Huang S
    Signal Transduct Target Ther; 2020 Aug; 5(1):140. PubMed ID: 32820156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cancer cells with nucleic acid aptamers.
    Cerchia L; de Franciscis V
    Trends Biotechnol; 2010 Oct; 28(10):517-25. PubMed ID: 20719399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards targeted cancer therapy: Aptamer or oncolytic virus?
    Tan KX; Danquah MK; Sidhu A; Ongkudon CM; Lau SY
    Eur J Pharm Sci; 2017 Jan; 96():8-19. PubMed ID: 27593990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.
    Alibolandi M; Ramezani M; Sadeghi F; Abnous K; Hadizadeh F
    Int J Pharm; 2015 Feb; 479(1):241-51. PubMed ID: 25529433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Theranostics Against Solid Cancer Using Metal Bond Milk Protein and Aptamers.
    Chaudhary S; Kanwar RK; Kanwar JR
    Curr Top Med Chem; 2017 Jun; 17(18):2100-2111. PubMed ID: 28137239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic acid aptamers in cancer research, diagnosis and therapy.
    Ma H; Liu J; Ali MM; Mahmood MA; Labanieh L; Lu M; Iqbal SM; Zhang Q; Zhao W; Wan Y
    Chem Soc Rev; 2015 Mar; 44(5):1240-56. PubMed ID: 25561050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.